Sebastien Irigaray

Title: The Innovations of Sebastien Irigaray

Introduction

Sebastien Irigaray is a notable inventor based in Mulhouse, France. He has made significant contributions to the field of biotechnology, particularly in the development of engineered heterodimeric proteins. His work has implications for therapeutic applications, showcasing the potential of innovative protein engineering.

Latest Patents

Sebastien Irigaray holds a patent for "Engineered heterodimeric proteins." This invention provides heterodimeric antibodies and fragments thereof, along with methods for their preparation. The innovation focuses on improving the pairing of heavy and light chains, where interface residues are mutated to ensure that each light chain strongly favors its cognate heavy chain. This advancement allows for the assembly of functional, heterodimeric antibodies or fragments in a co-transfected and co-expressed cellular environment. He has 1 patent to his name.

Career Highlights

Irigaray is currently associated with Novartis AG, a leading global healthcare company. His role at Novartis allows him to work at the forefront of pharmaceutical innovation, contributing to the development of new therapeutic solutions. His expertise in protein engineering is a valuable asset to the company's research and development efforts.

Collaborations

Throughout his career, Sebastien has collaborated with esteemed colleagues such as Regis Cebe and Darko Skegro. These collaborations have fostered a productive environment for innovation and have led to advancements in their respective fields.

Conclusion

Sebastien Irigaray's contributions to the field of biotechnology through his patent on engineered heterodimeric proteins exemplify the impact of innovative thinking in science. His work at Novartis AG and collaborations with other professionals further enhance the potential for future breakthroughs in therapeutic applications.